Stockscreener 앱 받기
0.39%
전일 마감가:
$292.89
열려 있는:
$292.89
하루 거래량:
1.38M
Relative Volume:
0.62
시가총액:
$157.07B
수익:
$34.76B
순이익/손실:
$6.62B
주가수익비율:
23.87
EPS:
12.223
순현금흐름:
$10.61B
1주 성능:
-2.36%
1개월 성능:
+4.49%
6개월 성능:
+4.26%
1년 성능:
-7.58%
1일 변동 폭
$290.66
$293.94
1주일 범위
$290.66
$303.85
52주 변동 폭
$253.30
$335.88
암젠 Stock (AMGN) Company Profile
명칭
Amgen Inc
전화
(805)447-1000
주소
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
AMGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
291.76 | 157.68B | 34.76B | 6.62B | 10.61B | 12.22 |
|
LLY
Lilly Eli Co
|
825.45 | 736.03B | 53.26B | 13.80B | -50.20M | 15.08 |
|
JNJ
Johnson Johnson
|
190.40 | 463.72B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
227.99 | 403.22B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
130.36 | 254.84B | 53.40B | 13.68B | 16.89B | 6.8864 |
|
MRK
Merck Co Inc
|
87.49 | 217.76B | 63.43B | 16.42B | 14.72B | 6.4861 |
암젠 Stock (AMGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 재개 | Raymond James | Mkt Perform |
| 2025-05-20 | 재개 | Guggenheim | Neutral |
| 2025-04-22 | 재개 | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Outperform |
| 2024-10-14 | 다운그레이드 | Truist | Buy → Hold |
| 2024-09-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-05-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 재개 | Raymond James | Mkt Perform |
| 2024-02-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-11-02 | 업그레이드 | Truist | Hold → Buy |
| 2023-10-20 | 재개 | JP Morgan | Neutral |
| 2023-10-17 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 재개 | BofA Securities | Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-04-24 | 재확인 | Oppenheimer | Outperform |
| 2023-03-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 재확인 | Truist | Buy |
| 2022-11-18 | 개시 | Credit Suisse | Underperform |
| 2022-10-31 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-10-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-02-09 | 재확인 | Barclays | Equal Weight |
| 2022-02-09 | 재확인 | Jefferies | Buy |
| 2022-02-09 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 재확인 | Oppenheimer | Outperform |
| 2022-02-09 | 재확인 | Wells Fargo | Equal Weight |
| 2022-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-12-09 | 재개 | Wells Fargo | Equal Weight |
| 2021-12-06 | 개시 | Goldman | Buy |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-09-23 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 개시 | Daiwa Securities | Buy |
| 2020-10-28 | 개시 | UBS | Neutral |
| 2020-10-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | 업그레이드 | Truist | Hold → Buy |
| 2020-10-09 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | 다운그레이드 | Truist | Buy → Hold |
| 2020-10-08 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 재개 | Guggenheim | Neutral |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-03-30 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-01-31 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 개시 | Raymond James | Mkt Perform |
| 2019-12-17 | 재개 | Morgan Stanley | Overweight |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-11-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-19 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2019-05-23 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
암젠 주식(AMGN)의 최신 뉴스
What dividend safety score for Amgen Inc. stockMarket Volume Report & Weekly Chart Analysis and Trade Guides - newser.com
Why global investors buy Amgen Inc. (AMG0) stockEntry Point & Expert Curated Trade Setup Alerts - newser.com
What is the fair value estimate for Amgen Inc. (AMG) stock in 2025July 2025 Market Mood & Real-Time Chart Pattern Alerts - newser.com
Amgen's (AMGN) "Buy (B-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Will Amgen Inc. (AMG0) stock extend growth storyGap Up & Breakout Confirmation Trade Signals - newser.com
Will Amgen Inc. (AMG0) stock recover faster than industry2025 Momentum Check & Fast Moving Stock Watchlists - newser.com
Amgen, Inc. Experiences Revision in Its Stock Evaluation Amid Market Dynamics - Markets Mojo
Will Amgen Inc. (AMG0) stock profit from AI boomQuarterly Profit Report & Free Technical Confirmation Trade Alerts - newser.com
Why global investors buy Amgen Inc. (AMG) stock2025 Technical Patterns & Stepwise Entry/Exit Trade Alerts - newser.com
UBS Raises PT on Amgen Inc. (AMGN) to $326 From $315, Keeps a Neutral Rating - MSN
Amgen Inc. stock daily chart insightsMarket Activity Report & Risk Controlled Daily Trade Plans - newser.com
Will Amgen Inc. (AMG0) stock outperform energy sector in 2025Trade Risk Summary & Technical Buy Zone Confirmations - newser.com
Should I buy Amgen Inc. (AMG0) stock before earnings seasonTreasury Yields & AI Enhanced Market Trend Forecasts - newser.com
Biogen Takes Aim At Amgen’s Tavneos With Vanqua Licensing Pact - Citeline News & Insights
The Zacks Analyst Blog Highlights Amazon.com, Wells Fargo, Amgen, IDT and Village Super Market - Zacks Investment Research
Sumitomo Mitsui Trust Group Inc. Has $475.22 Million Holdings in Amgen Inc. $AMGN - MarketBeat
ESMO 25: What Was Behind Bemarituzumab’s Waning Efficacy In FORTITUDE-101? - Citeline News & Insights
Moloney Securities Asset Management LLC Sells 2,270 Shares of Amgen Inc. $AMGN - MarketBeat
Sector Gamma AS Reduces Stock Position in Amgen Inc. $AMGN - MarketBeat
Asset Management One Co. Ltd. Boosts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
FSM Wealth Advisors LLC Invests $440,000 in Amgen Inc. $AMGN - MarketBeat
First Citizens Bank & Trust Co. Raises Stake in Amgen Inc. $AMGN - MarketBeat
Strategic Blueprint LLC Raises Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Rep. Lisa C. McClain Sells Off Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know - sharewise.com
Top Research Reports for Amazon.com, Wells Fargo & Amgen - Yahoo Finance
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Has $16.73 Million Stake in Amgen Inc. $AMGN - MarketBeat
Paralel Advisors LLC Purchases New Shares in Amgen Inc. $AMGN - MarketBeat
Bleakley Financial Group LLC Increases Stock Position in Amgen Inc. $AMGN - MarketBeat
Principle Wealth Partners LLC Lowers Stock Position in Amgen Inc. $AMGN - MarketBeat
Exencial Wealth Advisors LLC Decreases Position in Amgen Inc. $AMGN - MarketBeat
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices - The New York Times
Halper Sadeh LLC Encourages Amgen Inc. Shareholders to Contact the Firm to Discuss Their Rights - The AI Journal
Amgen Inc. $AMGN Shares Purchased by Greatmark Investment Partners Inc. - MarketBeat
Ethic Inc. Boosts Position in Amgen Inc. $AMGN - MarketBeat
Amgen Abandons Patent For Way Of Boosting Drug Potency - Law360
Amgen Inc. $AMGN Shares Sold by ARK Investment Management LLC - MarketBeat
Amgen Inc. $AMGN Shares Bought by Parcion Private Wealth LLC - MarketBeat
AstraZeneca and Amgen’s Tezspire approved in EU for nasal polyps - Investing.com
Brookstone Capital Management Increases Stock Position in Amgen Inc. $AMGN - MarketBeat
Pacific Heights Asset Management LLC Boosts Holdings in Amgen Inc. $AMGN - MarketBeat
OMC Financial Services LTD Boosts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by D.A. Davidson & CO. - MarketBeat
Avidian Wealth Enterprises LLC Increases Stake in Amgen Inc. $AMGN - MarketBeat
AstraZeneca, Amgen's Severe Chronic Rhinosinusitis Drug Secures EU Approval - MarketScreener
Using flow based indicators on Amgen Inc.Rate Cut & Low Drawdown Momentum Trade Ideas - newser.com
Will Amgen Inc. (AMG0) stock benefit from mergersPortfolio Update Report & Growth Oriented Trading Recommendations - newser.com
암젠 (AMGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.17%
0.51%
자본화:
|
볼륨(24시간):